245 related articles for article (PubMed ID: 36688929)
1. Biogenesis of JC polyomavirus associated extracellular vesicles.
Morris-Love J; O'Hara BA; Gee GV; Dugan AS; O'Rourke RS; Armstead BE; Assetta B; Haley SA; Atwood WJ
J Extracell Biol; 2022 May; 1(5):. PubMed ID: 36688929
[TBL] [Abstract][Full Text] [Related]
2. JC Polyomavirus Uses Extracellular Vesicles To Infect Target Cells.
Morris-Love J; Gee GV; O'Hara BA; Assetta B; Atkinson AL; Dugan AS; Haley SA; Atwood WJ
mBio; 2019 Apr; 10(2):. PubMed ID: 30967463
[TBL] [Abstract][Full Text] [Related]
3. Complexities of JC Polyomavirus Receptor-Dependent and -Independent Mechanisms of Infection.
Morris-Love J; Atwood WJ
Viruses; 2022 May; 14(6):. PubMed ID: 35746603
[TBL] [Abstract][Full Text] [Related]
4. Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples.
Scribano S; Guerrini M; Arvia R; Guasti D; Nardini P; Romagnoli P; Giannecchini S
J Clin Virol; 2020 Jul; 128():104435. PubMed ID: 32442760
[TBL] [Abstract][Full Text] [Related]
5. JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.
Mayberry CL; Soucy AN; Lajoie CR; DuShane JK; Maginnis MS
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700597
[TBL] [Abstract][Full Text] [Related]
6. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
7. GRK2 mediates β-arrestin interactions with 5-HT
Mayberry CL; Wilczek MP; Fong TM; Nichols SL; Maginnis MS
J Virol; 2021 Mar; 95(7):. PubMed ID: 33441347
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
9. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
[TBL] [Abstract][Full Text] [Related]
10. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
11. High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.
Bond ACS; Crocker MA; Wilczek MP; DuShane JK; Sandberg AL; Bennett LJ; Leclerc NR; Maginnis MS
Antiviral Res; 2024 Feb; 222():105817. PubMed ID: 38246207
[TBL] [Abstract][Full Text] [Related]
12. JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.
Maginnis MS; Nelson CD; Atwood WJ
J Neurovirol; 2015 Dec; 21(6):601-13. PubMed ID: 25078361
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3'-Kinase γ Facilitates Polyomavirus Infection.
Clark P; Gee GV; Albright BS; Assetta B; Han Y; Atwood WJ; DiMaio D
Viruses; 2020 Oct; 12(10):. PubMed ID: 33092168
[TBL] [Abstract][Full Text] [Related]
14. JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.
Mayberry CL; Nelson CDS; Maginnis MS
Curr Clin Microbiol Rep; 2017 Sep; 4(3):132-141. PubMed ID: 28989857
[TBL] [Abstract][Full Text] [Related]
15. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
16. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
17. The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity.
Ströh LJ; Maginnis MS; Blaum BS; Nelson CD; Neu U; Gee GV; O'Hara BA; Motamedi N; DiMaio D; Atwood WJ; Stehle T
J Virol; 2015 Jun; 89(12):6364-75. PubMed ID: 25855729
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles.
Oberholster L; Mathias A; Perriot S; Blaser E; Canales M; Jones S; Culebras L; Gimenez M; Kaynor GC; Sapozhnik A; Richetin K; Goelz S; Du Pasquier R
Microbiol Spectr; 2023 Dec; 11(6):e0275123. PubMed ID: 37815349
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of JC polyomavirus infectivity by the retrograde transport inhibitor Retro-2.1.
Treasure T; Nelson CDS
Microbiol Immunol; 2020 Dec; 64(12):783-791. PubMed ID: 32965709
[TBL] [Abstract][Full Text] [Related]
20. The human JC polyomavirus (JCPyV): virological background and clinical implications.
Hirsch HH; Kardas P; Kranz D; Leboeuf C
APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
